CENTONZE, DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 142.362
AS - Asia 18.556
EU - Europa 13.159
SA - Sud America 2.471
AF - Africa 222
Continente sconosciuto - Info sul continente non disponibili 61
OC - Oceania 54
AN - Antartide 1
Totale 176.886
Nazione #
US - Stati Uniti d'America 141.954
SG - Singapore 8.962
CN - Cina 3.309
IT - Italia 2.161
BR - Brasile 2.084
HK - Hong Kong 1.913
RU - Federazione Russa 1.894
UA - Ucraina 1.818
DE - Germania 1.677
KR - Corea 1.543
IE - Irlanda 1.468
VN - Vietnam 1.256
FR - Francia 830
GB - Regno Unito 802
SE - Svezia 671
FI - Finlandia 544
JP - Giappone 466
PL - Polonia 366
NL - Olanda 303
IN - India 246
CA - Canada 226
AR - Argentina 153
ID - Indonesia 119
BD - Bangladesh 102
ES - Italia 99
IQ - Iraq 98
MX - Messico 97
TR - Turchia 97
ZA - Sudafrica 86
AT - Austria 85
BE - Belgio 64
CZ - Repubblica Ceca 63
EC - Ecuador 56
UZ - Uzbekistan 52
EU - Europa 50
RO - Romania 48
AU - Australia 47
CL - Cile 46
IR - Iran 38
PH - Filippine 38
BG - Bulgaria 35
SA - Arabia Saudita 35
MA - Marocco 34
PY - Paraguay 34
LT - Lituania 32
CH - Svizzera 28
CO - Colombia 28
PK - Pakistan 27
MY - Malesia 25
GR - Grecia 24
KE - Kenya 23
AE - Emirati Arabi Uniti 22
DK - Danimarca 22
KG - Kirghizistan 22
UY - Uruguay 21
PE - Perù 20
TN - Tunisia 20
VE - Venezuela 20
EG - Egitto 19
PT - Portogallo 19
IL - Israele 18
AL - Albania 17
JO - Giordania 17
HR - Croazia 16
KZ - Kazakistan 16
DM - Dominica 15
NP - Nepal 15
TW - Taiwan 15
DZ - Algeria 14
TH - Thailandia 14
AZ - Azerbaigian 13
DO - Repubblica Dominicana 13
RS - Serbia 13
OM - Oman 12
LB - Libano 11
JM - Giamaica 10
CR - Costa Rica 9
NO - Norvegia 9
SI - Slovenia 9
BO - Bolivia 8
HU - Ungheria 8
TT - Trinidad e Tobago 8
A2 - ???statistics.table.value.countryCode.A2??? 7
BH - Bahrain 7
CY - Cipro 7
HN - Honduras 7
LV - Lettonia 7
BN - Brunei Darussalam 6
KH - Cambogia 6
NG - Nigeria 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
MN - Mongolia 5
MT - Malta 5
NZ - Nuova Zelanda 5
AM - Armenia 4
CI - Costa d'Avorio 4
EE - Estonia 4
GE - Georgia 4
GT - Guatemala 4
Totale 176.821
Città #
Woodbridge 39.298
Wilmington 37.934
Houston 32.850
Fairfield 4.469
Singapore 4.038
Ann Arbor 3.272
Ashburn 2.460
Hong Kong 1.876
San Jose 1.791
Seattle 1.786
Chandler 1.738
Jacksonville 1.593
Cambridge 1.529
Dublin 1.418
Beijing 1.099
Medford 1.024
The Dalles 709
Santa Clara 628
New York 617
Dearborn 560
Rome 521
Lawrence 485
Los Angeles 425
Ho Chi Minh City 401
Tokyo 397
Dallas 367
Zhengzhou 351
Council Bluffs 333
Buffalo 323
Hanoi 275
Kraków 273
Hangzhou 272
Moscow 259
Lauterbourg 245
Mülheim 241
San Diego 236
São Paulo 214
Menlo Park 199
Milan 184
Norwalk 172
Munich 158
Orem 149
London 139
Chicago 120
Redwood City 107
Helsinki 102
Shanghai 96
Guangzhou 95
San Mateo 86
Lappeenranta 85
Frankfurt am Main 84
Redondo Beach 82
Nuremberg 81
Mountain View 80
North Bergen 80
Chennai 78
University Park 78
Jakarta 74
Montreal 74
Falls Church 69
Rio de Janeiro 65
Seoul 65
Toronto 63
Warsaw 63
Brooklyn 60
Saint Petersburg 60
Verona 59
San Francisco 58
Atlanta 57
Amsterdam 56
Brussels 56
Palo Alto 55
Detroit 54
Hefei 54
Nanjing 54
Johannesburg 50
Belo Horizonte 49
Salt Lake City 48
Manchester 47
Brno 46
Colorado Springs 46
Denver 45
Haiphong 45
Mcallen 45
Boardman 44
Columbus 44
Philadelphia 43
Stockholm 43
Da Nang 41
Phoenix 40
Brasília 39
Naples 38
Tashkent 37
Kunming 36
Vienna 36
Paris 35
Boston 33
Poplar 33
Baghdad 32
Mumbai 32
Totale 150.685
Nome #
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression 723
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 659
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 610
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 607
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 606
TRPV1 channels facilitate glutamate transmission in the striatum 596
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 590
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma 581
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 574
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 574
Neurophysiology of synaptic functioning in multiple sclerosis 573
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 566
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 547
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 547
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 527
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 524
KFLC Index utility in multiple sclerosis diagnosis: Further confirmation 522
miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation 520
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 515
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 514
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia 513
The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis 512
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 511
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients 508
Effects of postural exercises in patients with Parkinson's disease and Pisa syndrome: A pilot study 507
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 506
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 505
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 504
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 503
K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis 502
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy 502
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 500
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 497
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 492
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 484
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 483
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 479
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads 479
Subclinical central inflammation is risk for RIS and CIS conversion to MS 476
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 476
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 475
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 474
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 473
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 473
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 472
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 472
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 472
Muscarinic IPSPs in rat striatal cholinergic interneurones 471
Treatment decisions for patients with active multiple sclerosis 470
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 469
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 468
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 468
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 467
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 467
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans 466
Abnormal brain lateralization and connectivity in schizophrenia 466
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes 466
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 466
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 465
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 465
A Substrate Trapping Mutant Form of Striatal-Enriched Protein Tyrosine Phosphatase Prevents Amphetamine-Induced Stereotypies and Long-Term Potentiation in the Striatum 463
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 463
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 462
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 462
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 461
Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis 461
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 460
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 460
TRPV1 channels regulate cortical excitability in humans 460
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis 459
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 459
Disability in multiple sclerosis: When synaptic long-term potentiation fails 459
D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801 457
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis 456
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 456
Synaptic transmission in the striatum: from plasticity to neurodegeneration 455
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 455
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 455
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 454
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 453
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis 452
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 452
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis 452
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 452
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 452
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis 451
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management 451
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 450
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis 449
Transcranial direct current stimulation (tdcs) does not produce acute urodynamic changes 449
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 449
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes 448
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 448
Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis 447
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 447
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP 446
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis 445
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 445
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 445
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 445
Totale 48.944
Categoria #
all - tutte 406.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 406.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.671 0 0 0 0 0 0 0 0 0 470 870 331
2021/20224.728 193 335 187 239 107 671 203 201 427 541 219 1.405
2022/20235.738 745 376 290 610 344 1.499 546 291 395 41 446 155
2023/20241.872 259 72 135 110 161 433 156 98 34 64 33 317
2024/202513.492 356 2.704 1.245 654 477 1.041 1.003 507 1.040 1.084 1.894 1.487
2025/202618.016 1.509 1.076 2.284 1.299 2.034 617 2.476 2.484 2.393 1.844 0 0
Totale 178.697